The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 27, 2018

Filed:

Apr. 06, 2016
Applicant:

Salk Institute for Biological Studies, La Jolla, CA (US);

Inventors:

Jae Myoung Suh, San Diego, CA (US);

Michael Downes, San Diego, CA (US);

Ronald M. Evans, La Jolla, CA (US);

Annette Atkins, San Diego, CA (US);

Senyon Choe, Solana Beach, CA (US);

Witek Kwiatkowski, San Diego, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/18 (2006.01); C07K 14/50 (2006.01); A61K 45/06 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1825 (2013.01); A61K 45/06 (2013.01); C07K 14/50 (2013.01); C07K 14/501 (2013.01); C07K 14/503 (2013.01); A61K 38/00 (2013.01); C07K 2319/00 (2013.01);
Abstract

The present disclosure provides chimeric proteins having an N-terminus coupled to a C-terminus, wherein the N-terminus comprises an N-terminal portion of fibroblast growth factor (FGF) 2 and the C-terminus comprises a portion of an FGF1 protein, wherein the chimeric protein comprises at least 95% sequence identity to SEQ ID NO: 9, 10, 11, 12 or 13. Also provided are nucleic acid molecules that encode such proteins, and vectors and cells that include such nucleic acids. Methods of using the disclosed molecules to reduce blood glucose levels are also provided.


Find Patent Forward Citations

Loading…